A retrospective analysis of the brain structure by MRI shows alterations in white matter in patients with myotonic dystrophy type…
Articles by Patricia Inácio, PhD
Researchers have found that certain cognitive functions, specifically those requiring sequential processing of auditory and visual information, do not improve…
Translarna (ataluren) is a promising drug for the treatment of Duchenne muscular dystrophy (DMD) and cystic fibrosis. A team of scientists at…
Researchers have found that a specific protein, CD82, is a marker for muscle stem cells and its expression is reduced in…
An international team of researchers has reviewed the latest treatments targeting non-muscle cells in the heart responsible for cardiac scarring. The information is…
Catabasis Pharmaceuticals, in a joint initiative with Parent Project Muscular Dystrophy (PPMD), recently hosted the webinar “MoveDMD: A Clinical…
University of Chicago researchers developed a DNA nanosensor that measures the physiological concentration of chloride with a high degree of…
Deflazacort, a glucocorticoid drug, was shown to improve muscle strength in boys with Duchenne muscular dystrophy (DMD) in a clinical trial performed…
FibroGen, a biotechnology company with expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology, recently announced…
In a new study entitled “Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype,” a team of researchers identified a…